Khosla, VCs plow US$100m into blood test startup using AI

Khosla, VCs plow US$100m into blood test startup using AI
(Image: Bloomberg)
Bloomberg
(Bloomberg) -- Blood-testing company Karius Inc. raised US$100 million (NZ$166.8m) in a new funding round from investors, and will use the cash to get its technology for detecting hard-to-identify infections into more hospitals. The funding round was led by existing investor Khosla Ventures alongside 5AM Ventures and Gilde Healthcare. The company declined to give its valuation. Redwood City, California-based Karius’ blood tests look for pathogens by comparing fragments of microbial DNA with a database of 20,000 genomic reference...

More Technology

Tech billionaires need a break from reality-distortion fields
Technology Opinion

Tech billionaires need a break from reality-distortion fields

Novel forms of power require novel checks and balances.

Hospitality tech firm Bustle brewing up success
Retail

Hospitality tech firm Bustle brewing up success

App for cafes is steaming ahead with a plan to grow to 5000 customers in three markets.

AI policy under Trump: what it means for NZ
Technology Business of Tech

AI policy under Trump: what it means for NZ

In this week’s episode, Peter talks to Sarah Box, an MBIE digital policy specialist.

Peter Griffin 03 Apr 2025